The complete series of videos showing what PRISM is about is now available on YouTube

In this series of videos, you’ll discover more about the PRISM project and its aims!

In the first video Martien Kas, the project co-ordinator, introduces the project.

In this video, you will discover how PRISM implements innovative (digital) technologies, such as the smartphone app BEHAPP, to assess social withdrawal and other behaviours in Schizophrenia, major depression and Alzheimer’s patients.

In this video, Martien Kas, the PRISM project co-ordinator, explains how the project will increase our neurobiological knowledge and improve predictive model systems for Schizophrenia, major depression and Alzheimer’s, to accelerate the drug discovery process.

PRISM aims to understand the neurobiological basis underlying social and cognitive deficits that are common across neuropsychiatric disorders. Measuring neuronal activity through EEG is one of the technologies used by project to investigate the neurobiological basis. Discover more in this new video of the PRISM series.

The fifth PRISM video “Visualizing the morphology of neural circuits”

>/figure>

The final PRISM video “Conclusion and perspectives of PRISM

>/figure>



EUFAMI’s 7th European Family Congress

Dr. Gerry Dawson, P1vital® Ltd, is representing PRISM at the EUFAMI’s 7th European Family Congress.

The Congress will be of interest to all family members, family carers/informal carers, and persons with lived experience of mental ill health, as well as healthcare professionals working, or with an interest, in mental health related fields.

Policy makers will also find this year’s Congress particularly interesting as preliminary findings of EUFAMI’s “Economic Case” project will be unveiled.

The Congress will take place in Helsinki, Finland, on 19th and 20th September 2019, under the auspices of the Finnish Presidency of the EU.

Click here to see the full programme.



Neuronet Scientific Coordination Board meeting

Neuronet Scientific Coordination Board meeting brings together project leaders from across the IMI neurodegenerative disease portfolio, encompassing EUR 260 million of funding.

Read more



The PRISM consortium has been awarded the Translational Neuroscience Prize 2019

The prize is given annually during the Dutch Neuroscience meeting and aims to acknowledge an individual or team of researchers for recent innovative research that translates to an application beyond that of the laboratory.



CORDIS published an article about the results of PRISM

CORDIS (the European Commission’s primary service for EU-funded research results) published an article about the results of PRISM, which you can read here.

The article is included in a Results Pack on The Brain, based on a request from IMI, DG RTD, ERCEA, DG CNECT. The full Results Pack can be found here.



Prof. Dr. Barbara Franke receives royal honours – CONGRATS!

Barbara Franke, Professor of Molecular Psychiatry at the Radboud University Medical Center in Nijmegen, received a royal honours for her academic work on psychiatric disorders, ADHD in particular. She was awarded Knighthood in the Order of the Netherlands Lion.



Press release, PRISM project: Scientists unveil plans to identify common social and cognitive elements in patients with Alzheimer’s disease, Depression, Schizophrenia

European scientists have mapped out a potentially radical new way to identify the causes of serious mental health conditions. The industry/academia PRISM consortium had developed a comprehensive plan, which aims to identify common links between Alzheimer’s disease, depression, and schizophrenia. This is published today in a special edition of Neuroscience & BioBehavioral Reviews. Click here to read the whole press release.


In a series of 13 articles in Neuroscience & BioBehavioral Reviews, the joint academia and Industry PRISM consortia (funded under the EU’s Innovative Medicine Initiative) sets out the philosophical rationale, biological background and the carefully designed research plan. See link at: https://www.sciencedirect.com/journal/neuroscience-and-biobehavioral-reviews/vol/97